Consolidated Statements Of Operations And Comprehensive Loss (Unaudited) - USD ($) shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Net revenue	$ 9,531,000	$ 6,539,000	$ 26,780,000	$ 14,260,000
Cost of revenue	4,689,000	4,265,000	15,157,000	9,692,000
Gross profit	4,842,000	2,274,000	11,623,000	4,568,000
Operating expenses:
Sales and marketing	3,451,000	2,678,000	10,315,000	7,475,000
General and administrative	2,479,000	2,300,000	8,613,000	7,446,000
Engineering and development	1,540,000	963,000	4,506,000	2,644,000
Loss on patent litigation settlement	29,000	0	190,000	0
Total operating expenses	7,499,000	5,941,000	23,624,000	17,565,000
Loss from operations	(2,657,000)	(3,667,000)	(12,001,000)	(12,997,000)
Gain (Loss) on foreign currency transactions	(36,000)	53,000	(172,000)	(68,000)
Interest expense, net	(569,000)	(568,000)	(1,727,000)	(1,782,000)
Gain on debt forgiveness	0	0	3,014,000	0
Other income, net	0	4,209,000	0	4,209,000
Non-operating gain (loss), net	(605,000)	3,694,000	1,115,000	2,359,000
Loss before income tax (provision) benefit	(3,262,000)	27,000	(10,886,000)	(10,638,000)
Income tax (provision) benefit	(14,000)	(15,000)	7,000	(49,000)
Net income (loss)	(3,276,000)	12,000	(10,879,000)	(10,687,000)
Other comprehensive loss items:
Foreign currency translation adjustments	(90,000)	111,000	(173,000)	167,000
Comprehensive income (loss)	(3,366,000)	123,000	(11,052,000)	(10,520,000)
Net income (loss)	(3,276,000)	12,000	(10,879,000)	(10,687,000)
Deemed dividend on convertible preferred stock	(9,000)	(17,378,000)	(546,000)	(17,378,000)
Net loss attributable to common stockholders	$ (3,285,000)	$ (17,366,000)	$ (11,425,000)	$ (28,065,000)
Net loss per share attributable to common stockholders:
Basic	$ (0.02)	$ (0.21)	$ (0.08)	$ (0.56)
Diluted	$ (0.02)	$ (0.21)	$ (0.08)	$ (0.56)
Shares used in the calculation of net loss per share:
Basic	151,941	81,341	145,809	50,366
Diluted	151,941	81,341	145,809	50,366